Publication :
- Pongtanakul B, Narkbunnam N, Veerakul G, Sanpakit K, Viprakasit V, Tanphaichitr VS, Suvatte V. Dengue hemorrhagic fever in patients with J Med Assoc Thai 2005;88(suppl 8): S80-85.
- Pongtanakul B, Das PK, Charpentier K, Dror, Y. Outcome of children with aplastic anemia treated with immunosuppressive Pediatr Blood cancer 2008; 50 :52-57.
- Chuansumrit A, Pongtanakul B, Kadegasem P, Sasanakul W, Chotsupakarn S, Kitpoka P, Wongwerawattanakoon P, Benjarachandra Accurate bedside diagnostic kit for haemophilia A and B. Haemophilia 2009;15(1):361-4.
- Buaboonnam J, Neungton C, Pongtanakul B, Vathana N, Sanpakit K: case report: Infantile Hepatic Hemangioma Treated with Propanolol. J Hematol Transfus Med. 2011;21:33-36
- Thongkitpreecha P, Kangsadalampai 0, Pongtanakul B, Meksawan Nutritional status in patients with thalassemia intermedia. J Hematol Transfus Med 2011;21:167-76.
- Saiviroonporn P, Viprakasit V, Maneesai A, Siritanaratkul N, Pongtanakul B, Wood JC, Krittayaphong R. Inter-site Validation of the Pixel-Wise Method for Cardiac T2* Analysis in Transfusion -Dependent Thai Thalassemia Patients. J Med Assoc Thai 2012; 95 (suppl.1) : s178-s185
- Hanamornroongruang S, Treetipsatit J, Pongtanakul B, Seangchai N. A 13-year old female with Xp11.2 translocation renal cell carcinoma; the first case diagnosed at Siriraj Hospital. J Med Assoc Thai 2012; 95:964-8.
- Viprakasit V, Nuchprayoon I, Chuansumrit A, Torcharus K, Pongtanakul B, Laothamatas J, Srichairatanakool S, Pooliam J, Supajitkasem S, Suriyaphol P, Tanphaichitr VS, Tuchinda S. Deferiprone (GPO-L-ONE®) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase Ill pediatric study (GPO-L-ONE; A001) from Thailand. Am J Hematol 2013;88 :251-60.
- Pongtanakul B, Viprakasit V. Twice daily deferasirox significantly improves clinical efficacy in transfusion dependent thalassaemias who were inadequate responders to standard once daily dose. Blood Cells Mol Dis 2013;51:96-7.
- Pongtanakul B, Sanpakit K, Chongkolwatana V, Viprakasit V. Normal cognitive functioning in a patient with Hb Bart’s hydrops successfully cured by hematopoietic SCT. Bone Marrow Transplant. 2014 ;49:155-6. doi:10.1038/bmt.2013.131.
- Veskitkul J, Ruangchira-Urai R, Charuvanij S, Pongtanakul B, Udomittipong K, Vichyanond P. Asthma-like symptoms as a presentation of antiphospholipid syndrome. Pediatr Pulmonol. 2015 Feb;50:E1-4. doi: 10.1002/ppul.23079.
- Anurathapan U, Pakakasama S, Mekjaruskul P, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Pongtanakul B, Rujkijyanont P, Meekaewkunchorn A, Sruamsiri R, Ungkanont A, lssaragrisil S, Andersson BS, Hongeng S. Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk Stratification. Bioi Blood Marrow Transplant. 2014;20:2066-71. doi:10.1016/j. bbmt.2014.07.016.
- Grainger JD, Locatelli F, Chotsampancharoen T, Donyush E, Pongtanakul B,Komvilaisak P, Sosothikul D, Drelichman G, Sirachainan N, Holzhauer S, Lebedev V, Lemons R, Pospisilova D, Ramenghi U, Bussel JB, Bakshi KK, Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet. 2015 Oct 24;386(10004):1649-58. doi: 10.1016/S0140-6736(15)61107-2. Epub 2015 Jul 28.
- Chuansumrit A, Natesirinilkul R, Pongtanakul B, Tangnararatchakit K,
Sirachainan N, Tantiworavit A, Charoenkwan P, Yoksan S. Dengue Infection in
Pediatric Patients with Thalassemia: Aggravation of Anemia. J Hematol Transfus
Med 2015;25:209-19.
- Ngarmpattarangkoon D, Pongtanakul B, Chanvorachote P, Meksawa K. Effect of vitamin E
supplementation on oxidative stress in non-transfusion-dependent thalassemia. Progr in
Nutr 2016:18 :258-65.
- Pongtanakul B, Wongthawatchai P, Vathana N, Narkbunnam N. Effect of long term
Desferrioxamine treatment on final height in children with transfusion dependent
thalassemia. J Hematol Transfus Med.2017;27:145-150.
- Sanpakit K, Pongtanakul B, Narkbunnam N, Viprakasit V, Veerakul G, Tanphaichitr V, Issaragrilsil S, Suvatte V. How can we get the best outcomes from cord blood stem cell transplantation (CBSCT) in severe thalassemic patients: when does the cell number really matter? Southeast Asian J Trop Med Public Health. 2017; 48 (suppl 2) :192-201.